TORACOBIFEMORAL BYPASS IN A PATIENT WHO UNDERWENT REPEATED INTERVENTIONS ON THE AORTO-FEMORAL SEGMENT DUE TO ATHEROSCLEROTIC LESIONS
https://doi.org/10.21518/2307-1109-2018-2-130-134
Abstract
Aortobifemoral bypass is still the gold standard treatment in surgery of the aortofemoral segment. The 1980s – 1990s classic publications showed that primary patency ranges from 76–95% in 5 years, and 75–85% in 10-years [1, 2]. Thrombosis of both branches of the bifurcation prosthesis occurs in 1–4% of patients. These patients may undergo thrombectomy with reconstruction of the distal anastomoses, re-aortofemoral prosthetics and, finally, extraanatomic bypass surgery.
About the Authors
Andrey E. ZotikovRussian Federation
Dr. of Sci. (Med.), Professor, Leading Researcher, Surgeon of the Vascular Surgery Department
tel.: +7(499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
Evgeny G. Myltsev
Russian Federation
Resident Medical Practitioner of the Vascular Surgery Department
tel.: +7 (499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
Irina E. Timina
Russian Federation
Dr. of Sci. (Med.), Senior Researcher, Physician of the Ultrasound Diagnosis and Treatment Department
tel.: +7 (499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
Vladimir A. Kulbak
Russian Federation
Cand. of Sci. (Med.), Researcher, Surgeon of the Vascular Surgery Department
tel.: +7 (499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
Alexander l. Golovyuk
Russian Federation
Cand. of Sci. (Med.), Surgeon of the Vascular Surgery Department
tel.: +7 (499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
Anzhelika V. Kozhanova
Russian Federation
Anesthesiologist-Reanimatologist of the Anaesthesiology and Reanimation Department
tel.: +7 (499) 236-72-90
27 Bolshaya Serpukhovskaya, 117997, Moscow
References
1. Nevelsteen A., Suy R. Graft occlusion following aortofemoral Dacron bypass. Ann. Vasc. Surg. 1991; 5: 32-7.
2. Szilagyi D.E., Elliott J.P. Jr, Smith R.F., Reddy D.J., Mcpharlin M. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J. Vasc. Surg. 1986; 3: 421-36.
3. Crawford J.D., Scali S.T., Giles K.A., Back M.R., Fatima J., Arnaoutakis D.K., Berceli S.A., Upchurch G.J., Huber T.S. Contemporary outcomes of thoracofemoral bypass. J. Vasc. Surg. 2018 oct 3.
4. Passman M.A., Farber M.A., Criado E., Marston W.A., Burnham S.J., Keagy B.A. Descending thoracic aorta to iliofemoral artery bypass grafting: a role for primary revascularization for aortoiliac occlusive disease? J. Vasc. Surg. 1999; 29: 249-58.
5. Koksal C., Kocamaz O., Aksoy E., Cakalagaoglu C., Kara I., Yanartas M., et al. thoracic aortobifemoral bypass in treatment of juxtarenal Leriche syndrome (midterm results). Ann. Vasc. Surg. 2012; 26: 1085-92.
6. Sapienza P., Mingoli A., Feldhaus R.J., Napoli F., Marsan A., Franceschini M., et al. Descending thoracic aorta-to-femoral artery bypass grafts. Am. J. Surg. 1997; 174: 662-6.
7. Reppert A.E., Jazaeri O., Babu A., Greenberg J.I., Deluka E., Nehler M.R., et al. Minimal thoracotomy thoracic bifemoral bypass in the endovascular era. Ann. Vasc. Surg. 2014; 28: 1420-5.
8. Branchereau A., Espinoza H., Rudondy P., Magnan P.E., Reboul J. Descending thoracic aorta as an inflow source for late occlusive failures following aortoiliac reconstruction. Ann. Vasc. Surg. 1991; 5: 8-15.
9. Bowes D.E., Keagy B.A., Benoit C.H., et al. Descending thoracic aortobifemoral bypass for Coccluded abdominal aorta: retroperitoneal route without an abdominal incision. J. Cardovasc. Surg. 1985; 26: 41-5.
10. Cronenwett J.L., Johnston K.W. Rutherford`s vascular surgery. 7th edition. 1649.
Review
For citations:
Zotikov A.E., Myltsev E.G., Timina I.E., Kulbak V.A., Golovyuk A.l., Kozhanova A.V. TORACOBIFEMORAL BYPASS IN A PATIENT WHO UNDERWENT REPEATED INTERVENTIONS ON THE AORTO-FEMORAL SEGMENT DUE TO ATHEROSCLEROTIC LESIONS. Aterotromboz = Atherothrombosis. 2018;(2):130-134. (In Russ.) https://doi.org/10.21518/2307-1109-2018-2-130-134

This work is licensed under a Creative Commons Attribution Attribution-NonCommercial-NoDerivs License.